Zahra Mahmoudjafari

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

Mohamed A. Kharfan‐Dabaja, Ambuj Kumar, Ernesto Ayala et al. · Transplantation and Cellular Therapy · 2021 · 181 citations · Full text

Medicine, Hematology, Immunology +16

Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access

Nausheen Ahmed, Moazzam Shahzad, Ernie Shippey et al. · Transplantation and Cellular Therapy · 2022 · 139 citations · Full text

Public Health, Immunology, Cancer Epidemiology +16

Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience

Danai Dima, James A. Davis, Nausheen Ahmed et al. · Transplantation and Cellular Therapy · 2023 · 78 citations

Medicine, Oncology, Pharmacotherapy +14

American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States

Zahra Mahmoudjafari, Kelly G. Hawks, Angela Hsieh et al. · Biology of Blood and Marrow Transplantation · 2018 · 74 citations · Full text

Pharmacy, Hematology, Regulatory Pharmacy +9

Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy

Danai Dima, Al‐Ola Abdallah, James A. Davis et al. · Blood Cancer Journal · 2024 · 41 citations · Full text

Medicine, Hematology, Oncology +16